Quick Takeaways
- Samsara BioCapital, L.P. filed SCHEDULE 13G/A for Palvella Therapeutics, Inc. Common Stock, $0.001 par value per share (PVLA).
- Disclosed ownership: 3.1%.
- Date of event: 30 Jun 2025.
Samsara BioCapital, L.P. - 30 Jun 2025 SCHEDULE 13G/A Report for Palvella Therapeutics, Inc. Common Stock, $0.001 par value per share (PVLA)
- Filing Manager
- Samsara BioCapital, L.P.
- Reporting Manager
- Samsara BioCapital, L.P.
- Symbol
- PVLA
- Shares outstanding
- 10,959,452 shares
- Disclosed Ownership
- 339,743 shares
- Ownership
- 3.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 17:26:47 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 20 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Samsara BioCapital, L.P. disclosed 3.1% ownership in Palvella Therapeutics, Inc. Common Stock, $0.001 par value per share (PVLA) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 20 Dec 2024.
- Current filing was accepted on 14 Aug 2025, 17:26.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Samsara BioCapital, L.P. | 3.1% | 339,743 | 0 | 339,743 | /s/ Srinivas Akkaraju | By Samsara BioCapital GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member | |
| Samsara BioCapital GP, LLC | 3.1% | 339,743 | 0 | 339,743 | /s/ Srinivas Akkaraju | By Srinivas Akkaraju, Managing Member | |
| Srinivas Akkaraju | 3.1% | 339,743 | 0 | 339,743 | /s/ Srinivas Akkaraju | Srinivas Akkaraju |